Systemic Therapy for Hepatocellular Carcinoma: Recent Advances
نویسندگان
چکیده
منابع مشابه
Recent Advances in Management of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignancies, ranking fifth in frequency among all malignancies in the world. HCC is characterised by rapid tumour growth and a high propensity of vascular invasion. Furthermore, 80% of patients with HCC have associated liver cirrhosis related to hepatitis B or C viral infection, which often restricts treatment options because of impaired...
متن کاملSorafenib, a systemic therapy for hepatocellular carcinoma.
Hepatocellular carcinoma is a lethal disease that requires a multidisciplinary approach and management. Surgical therapy offers long-term survival; however, few patients are candidates. There has been no accepted systemic therapy for this disease until recently. This article briefly discusses the role of RAS/RAF/MEK/ERK signaling pathway in the pathogenesis of the disease and the promising role...
متن کاملRecent Advances in Hemophilia Gene Therapy
Heterogeneous loss of function mutations at F8 and F9 genes causes X-linked recessive bleeding disorders, hemophilia A (HA) and hemophilia B (HB), respectively. HA is clinically indistinguishable from HB and accounts for more than 80% of hemophilia cases; the former affects 1/5000 and the latter 1/25000 male births worldwide. In Iran, it is estimated that around 4300 HA and 900 HB patients are ...
متن کاملrecent advances in radiofrequency ablation for the management of hepatocellular carcinoma
contexts hepatocellular carcinoma (hcc) is one of the most common malignant diseases in the world. because less than 20% of patients with hcc are resectable, various types of non-surgical treatment have been developed. evidence acquisition at present, radiofrequency ablation (rfa) is accepted as the standard local treatment for patients with hcc because of its superior local control and overall...
متن کاملRecent Advances in Liver Resection for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. The association of HCC with chronic liver disease (CLD) is well known and making treatment complex and challenging. The treatment of HCC must take into consideration, the severity of CLD, the stage of HCC, and the clinical condition of the patient. Liver resection (LR) is one of the most efficient treatments for patient...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kanzo
سال: 2018
ISSN: 0451-4203,1881-3593
DOI: 10.2957/kanzo.59.587